Completed
Topics
On March 1 and 2, 2021, the National Cancer Policy Forum convened a virtual workshop to examine the evidence base on how the Patient Protection and Affordable Care Act (ACA) has altered the landscape of cancer prevention and care delivery.
Featured publication
Workshop
·2022
The National Cancer Policy Forum of the National Academies of Sciences, Engineering, and Medicine convened a virtual workshop in March 2021 to examine the existing evidence base on how the Patient Protection and Affordable Care Act (ACA) has altered the landscape of cancer prevention and care delive...
View details
Description
A National Academies of Sciences, Engineering, and Medicine planning committee will organize and host a 1.5-day public workshop to examine the impact of the Patient Protection and Affordable Care Act (ACA) on cancer prevention and care (early detection, diagnosis, treatment, and survivorship). The workshop will feature invited presentations and panel discussions on topics that may include:
· The effects of ACA provisions such as:
o Coverage for certain preventive care services without patient cost sharing;
o Prohibition of exclusions for preexisting conditions;
o Coverage of children up to age 26 on a parent’s health insurance plan; and
o State-based Medicaid expansions.
· The impact of new organizational infrastructure (e.g., the Patient-Centered Outcomes Research Institute and Centers for Medicare and Medicaid Innovation), and their relevance to cancer research.
· The effects of payment reform demonstration projects (such as accountable care organizations and the oncology medical home pilot) on patient outcomes and the quality and efficiency of oncology care delivery; as well as the viability and sustainability of alternative payment models.
· Remaining evidence gaps and policy challenges and their impact on patients with cancer.
· Lessons learned from the design and implementation of the ACA that could inform future health care reform efforts.
The planning committee will develop the agenda for the workshop sessions, select and invite speakers and discussants, and moderate the discussions. A proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines.
Collaborators
Sponsors
American Association for Cancer Research
American Cancer Society
American College of Radiology
American Society of Clinical Oncology
Association of American Cancer Institutes
Association of Community Cancer Centers
Bristol Myers Squibb
Cancer Support Community
Centers for Disease Control and Prevention (CDC)
CEO Roundtable on Cancer
Flatiron Health
Merck
National Cancer Institute
National Comprehensive Cancer Network
National Patient Advocate Foundation
Novartis Oncology
Oncology Nursing Society
Pfizer Inc.
Sanofi
Society for Immunotherapy of Cancer
Staff
Lori Brenig
Rachel Austin